Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL116846

O=C(O)[C@@H](O)[C@H](O)C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 1.00
TP53 P04637 1/20 0.50
CYP2C9 P11712 2/20 0.45
PDE4A P27815 1/20 0.45
LMNA P02545 2/20 0.43
ALDH1A1 P00352 2/20 0.43
THRB P10828 1/20 0.43
RECQL P46063 1/20 0.43
CYP2C19 P33261 2/20 0.42
NFKB1 P19838 1/20 0.42
OR51E2 Q9H255 1/20 0.41
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
ABCB11 O95342 1/20 0.40
F2 P00734 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL30689288 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Cadaverine Tartrate SCHEMBL848 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Tartaric Acid SCHEMBL29430365 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Cadaverine Tartrate SCHEMBL1062721 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Cadaverine Tartrate SCHEMBL22768 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Cadaverine Tartrate SCHEMBL29382062 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Cadaverine Tartrate SCHEMBL31427568 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Tartaric Acid SCHEMBL5762 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Cadaverine Tartrate SCHEMBL1431070 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA
Cadaverine Tartrate SCHEMBL3065246 1.00 TSHR (1.00) TSHRTP53CYP2C9PDE4ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 11371 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747257-A1 SOLID STATE FORMS OF BUNTANETAP AND PROCESS FOR PREPARATION THEREOF Assia Chemical Industries Ltd. (IL) 2026-05-27 EP claimed
CN-122079801-A Synthesis method and analysis method of (1S, 4R) -4-amino-2-cyclopentene-1-carboxylic acid methyl ester tartrate 2026-05-26 CN claimed
CN-120736974-B Method for preparing calcium maleate, calcium cis-epoxy succinate or tartaric acid Ningbo Jinzhan Biotechnology Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-122079135-A Preparation method and application of dextrorotation molybdenum doped carbon dots 2026-05-26 CN claimed
US-12630520-B2 Left-handed bicyclic morpholine and salt thereof, preparation method therefor, pharmaceutical composition, and use INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) 2026-05-19 US claimed
WO-2026098867-A1 OXIDATIVE HAIR BRIGHTENING BY MEANS OF PERSULFATE, DICARBOXYLIC ACID, AND CITRULLINE HENKEL AG & CO. KGAA (DE) 2026-05-15 WO claimed
WO-2026098459-A1 CRYSTALLINE FORM OF SUBSTITUTED 2-(PYRROLIDIN-3-YL) ACETATE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海翊石医药科技有限公司 2026-05-15 WO claimed
EP-3210965-B2 PROCESS FOR THE PREPARATION OF (1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYL-PROPYL)-PHENOL GRUENENTHAL GMBH (DE) 2026-05-13 EP claimed
US-12616687-B2 Treatment of viral infection, disease or disorder using a selective sir agonist PRILENIA NEUROTHERAPEUTICS LTD. (IL) 2026-05-05 US claimed
WO-2026086809-A1 PROCESS FOR PREPARING 3- [ (3AS, 6AR) -5- {5-CHLORO-2- [ (1-METHYL-1H-PYRAZOL-4-YL) AMINO] PYRIMIDIN-4-YL} -3A-METHYL-OCTAHYDROPYRROLO [3, 4-C] PYRROLE-2-YL] -3-OXOPROPIONITRILE BEIJING INNOCARE PHARMA TECH CO., LTD. (CN) 2026-04-30 WO claimed
US-4464434-A Microencapsulated alkaloidal material and method of producing same CELANESE CORPORATION (US) 1984-08-07 US claimed
EP-0029811-B1 SHEATHED SURGICAL SUTURE FILAMENT AND METHOD FOR ITS PREPARATION ASSUT SA (CH) 1984-05-30 EP claimed
US-4353918-A ANTIINFLAMMATORY, ANTIRHEUMATIC CIBA-GEIGY CORPORATION (US) 1982-10-12 US claimed
EP-0029811-A1 Sheathed surgical suture filament and method for its preparation ASSUT SA (CH) 1981-06-03 EP claimed
WO-1981001368-A1 SHEATHED SURGICAL SUTURE FILAMENT AND METHOD FOR ITS PREPARATION BATTELLE MEMORIAL INSTITUTE (CH) 1981-05-28 WO claimed
US-4195645-A POLYSACCHARIDES, ALKALOIDS CELANESE CORPORATION (US) 1980-04-01 US claimed
US-4101380-A USING POLYOXYETHYLENE GLYCOL DERIVATIVES AND ACTIBATED CARBOXYLIC ESTERS RESEARCH PRODUCTS REHOVOT LTD. (IL) 1978-07-18 US claimed
US-4085138-A Process for optical resolution of crude trans-1,2-cyclohexanediamine EXXON RESEARCH & ENGINEERING CO. (US) 1978-04-18 US claimed
US-3957579-A HYDROLYSIS OF CIS-EPOXYSUCCINIC ACID USING ACHROMOBACTER OR ALCALIGENES TORAY INDUSTRIES, INC. (JA) 1976-05-18 US claimed
US-3953504-A Racemization of optically active tartaric acid NIPPON PEROXIDE CO., LTD. (JA) 1976-04-27 US claimed